Capsaicinoids [antikvár]

The potential role(s) of the scientific research works is (are) extremely well accepted in our days, when the Establishment of European Union celebrated its 50th years anniversary (2007). Consequently the countries of the European Union have chosen a new and common pathway for the economical, social and scientific development in Europe for the forthcoming time period (hopefully for all of the countries and for many centuries). Seven countries (France, West Germany, Italy, Spain, The Netherlands, Luxemburg, Belgium) established the European Economical Committee in Rome, Italy in 1957, when Europe demonstrated clearly the signs of survival over the Second World War to other parts of the Worid. Later on, this European Economical Committee has incorporated other countries including the countries liberated from the Soviet power. The final aim of these European political and economical changes is to establish an eminent, economically, politically and scientifically stable European Union. Hungary was accepted and entered the European Union by January 1, 2004. Thereafter many assets of our life have changed significantly (including economy, policy, social life, science). We have to try to find the most prominent lines still going on from the life in Hungary, which help us to reach the streams of the European Union. The pharmacological research and industry in Hungary were internationally well accepted by the different countries of Europe, North America (USA, Canada), Asia (Japan, China, India, and Pakistan). The essential and key role of so-called "innovative pharmacological research" has been especially accepted by the Hungarian Research Departments (including the Hungarian Academy of Sciences) and by the Hungarian Government. The different Regional University Science Centers (Debrecen, Budapest, Szeged and Pécs) have been established in 2004 by the Hungarian Government. Our (Pécs) University has received a grant for carrying out the innovative pharmacological research in the time period of 2005-2008 (National Office for Research and Technology "Pázmány Péter Program, RET-II, 08/2005"). The members (altogether 21) of the research are working in the University of Pécs, First Department of Medicine and Pharmaceutical Chemical Institute, Medical Faculty, University of Pécs, Hungary and PannonPharma Pharmaceutical Ltd. (Pécsvárad, Hungary). These researchers never worked together in a common project. So we found ourselves before an extremely new challenge in our common innovative pharmacologi- 11